RE:correct me if i'm wrongHi amateurhour. I think there are two separate issues in your post.
Regarding the CEO, in the short run (like Q1) it is far easier to present the business in a negative way. However, as last year's results demonstrate, you cannot do it over the course of the year as eventually they will sell product and they will be audited. Time is the CEO's thorn.
Had the CEO not failed in his buy out, we would not have known how the $2.25 price ended up being a fantastic deal - for him. If you look at the Deloitte valuation, many of the assumptions used to justify this price were later used in Q2 and Q3 last year, but at year end they no longer held any truth to them under the scrutiny of the audit. The only one that stuck was the write down of the property, plant and equipment and this was due to the method relied upon by the auditors, which is the takeover price, which was far below book value.
Regarding the share price, this is a thinly traded stock with over 60 million shares outstanding. The stock price can drive down and up with less than 1/4 of 1% of the shares exchanging hands (Friday's drop of 22% for example). The market price is only relevant if you think it is an opportunity to buy, or sell, based on the value you estimate you are receiving or giving away.